Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.31 USD
Change Today -0.01 / -0.76%
Volume 616.7K
ATHX On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John J. Harrington Ph.D.

Co-Founder, Chief Scientific Officer, Executive Vice President and Director, Athersys, Inc.
AgeTotal Calculated CompensationThis person is connected to 23 board members in 1 different organizations across 1 different industries.

See Board Relationships
47$728,590
As of Fiscal Year 2014

Background*

Dr. John J. Harrington, Ph.D. co-founded Athersys, Inc. in October 1995 and has been its Chief Scientific Officer and Executive Vice President since October 1995. Dr. Harrington is a Co-developer of the SMC technology, and has led the development of the RAGE technology for both gene discovery and commercial protein production applications. He has been a Director of Athersys, Inc., since June 2007. From 1994 to 1998, he had a research appointment at Case Western Reserve ...

Read Full Background

Corporate Headquarters*

3201 Carnegie Avenue
Cleveland, Ohio 44115

United States

Phone: 216-431-9900
Fax: 216-361-9495

Board Members Memberships*

1995-Present
Co-Founder, Chief Scientific Officer, Executive Vice President and Director

Education*

PhD
Stanford University
BA
University of California - San Diego

Other Affiliations*

Annual Compensation*

Salary$380,015
Bonus$82,000
Total Annual Compensation$462,015

Stock Options*

Restricted Stock Awards$88,862
All Other Compensation$10,523
Exercisable Options775,144
Unexercisable Options168,508
Total Number of Options943,652

Total Compensation*

Total Annual Cash Compensation$472,538
Total Short Term Compensation$462,015
Other Long Term Compensation$99,385
Total Calculated Compensation$728,590
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATHX:US $1.31 USD -0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$437.4K
Martin M. McGlynn Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc
StemCells Inc.
$789.5K
David J. Mazzo B.A (Hons), B.Sc. (Hons.), M.Sc., Ph.D.Chief Executive Officer and Director
Neostem, Inc.
--
Zami Aberman Executive Chairman and Chief Executive Officer
Pluristem Therapeutics, Inc.
$503.7K
Mark R. Weinreb M.S.Chairman, Chief Executive Officer and President
BioRestorative Therapies, Inc.
$675.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ATHERSYS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.